Department of Biological Sciences, Yarmouk University, 21163Irbid, Jordan.
Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacy Practice, Yarmouk University, Irbid, Jordan.
Endocr Metab Immune Disord Drug Targets. 2021;21(8):1504-1511. doi: 10.2174/1871530320666201023124544.
Activation of the Angiotensin II type 1 receptor (AT1R) has been implicated in the pathogenesis of the cardiovascular disease, while activation of Angiotensin II type 2 receptor (AT2R) leads to effects that are opposite to those mediated by AT1R. The interaction between female sex hormones and the renin-angiotensin system was proven to play an essential role in the pathological changes in the cardiovascular system.
To investigate the direct effect of estrogen and progesterone on arterial and cardiac AT1R and AT2R expression in vivo in male.
Male adult rats were assigned into four groups: Group 1 (control), group 2 (progesterone treated group; 10mg/kg), group 3 (estrogen treated group; 20μg/kg) and group 4 (progesterone; 10mg/kg + estrogen; 20μg/kg treated group). All treatments were administrated subcutaneously every second day for 21days.
Estrogen treatments increase the left ventricle (LV) protein expression of AT1R, and progesterone treatment decreased the LV protein expression of AT2R. In the aorta, estrogen treatment increased the mRNA expression levels of AT1R, while progesterone treatment increased the AT2R mRNA expression levels. Estrogen treatment decreases the LV and aortic endothelial nitric-oxide synthase (eNOS) mRNA levels while progesterone treatments decrease the LV eNOS mRNA levels but increase the aortic eNOS mRNA levels. The serum angiotensin II levels were increased by estrogen treatment only.
Both estrogen and progesterone treatments appear to have a harmful effect on the male rat hearts, possibly by increasing the protein expression of AT1R (for estrogen), decrease the protein and mRNA expression of AT2R (for progesterone), and decrease the eNOS mRNA levels (for both). However, it seems that progesterone but not estrogen exerts a vascular protective effect in males.
血管紧张素 II 型 1 受体(AT1R)的激活被认为与心血管疾病的发病机制有关,而血管紧张素 II 型 2 受体(AT2R)的激活则导致与 AT1R 介导的作用相反的作用。女性性激素与肾素-血管紧张素系统的相互作用被证明在心血管系统的病理变化中起着重要作用。
研究雌激素和孕激素对雄性动物体内动脉和心脏 AT1R 和 AT2R 表达的直接影响。
将成年雄性大鼠分为四组:第 1 组(对照组)、第 2 组(孕激素处理组;10mg/kg)、第 3 组(雌激素处理组;20μg/kg)和第 4 组(孕激素;10mg/kg+雌激素;20μg/kg 处理组)。所有治疗均为皮下注射,每两天一次,共 21 天。
雌激素治疗增加左心室(LV)AT1R 的蛋白表达,而孕激素治疗降低 LV 中 AT2R 的蛋白表达。在主动脉中,雌激素治疗增加 AT1R 的 mRNA 表达水平,而孕激素治疗增加 AT2R 的 mRNA 表达水平。雌激素治疗降低 LV 和主动脉内皮型一氧化氮合酶(eNOS)的 mRNA 水平,而孕激素治疗降低 LV eNOS 的 mRNA 水平,但增加主动脉 eNOS 的 mRNA 水平。只有雌激素治疗增加血清血管紧张素 II 水平。
雌激素和孕激素治疗似乎对雄性大鼠心脏都有不良影响,可能是通过增加 AT1R 的蛋白表达(对雌激素)、降低 AT2R 的蛋白和 mRNA 表达(对孕激素)以及降低 eNOS 的 mRNA 水平(对两者)。然而,似乎是孕激素而不是雌激素对男性具有血管保护作用。